Correction to: Parma consensus statement on metabolic disruptors

Autor: Jerrold J. Heindel, Frederick S. vom Saal, Bruce Blumberg, Patrizia Bovolin, Gemma Calamandrei, Graziano Ceresini, Barbara A. Cohn, Elena Fabbri, Laura Gioiosa, Christopher Kassotis, Juliette Legler, Michele La Merrill, Laura Rizzi, Ronit Machtinger, Alberto Mantovani, Michelle A. Mendez, Luisa Montanini, Laura Molteni, Susan C. Nagel, Stefano Parmigiani, Giancarlo Panzica, Silvia Paterlini, Valentina Pomatto, Jérôme Ruzzin, Giorgio Sartor, Thaddeus T. Schug, Maria E. Street, Alexander Suvorov, Riccardo Volpi, R. Thomas Zoeller, Paola Palanza

Publikováno v: Environmental Health, Vol 16, Iss 1, Pp 1-1 (2017)

Correction After publication of the article [1], it has been brought to our attention that the thirteenth author of this article has had their name spelt incorrectly. In the original article the spelling “Laura Rizzir” was used. In fact the corre

Externí odkaz: https://doaj.org/article/2254f78b0a4b4eee9a8b54b58f1d7d43

Obesity I: Overview and molecular and biochemical mechanisms

Autor: Robert H. Lustig, David Collier, Christopher Kassotis, Troy A. Roepke, Min Ji Kim, Etienne Blanc, Robert Barouki, Amita Bansal, Matthew C. Cave, Saurabh Chatterjee, Mahua Choudhury, Michael Gilbertson, Dominique Lagadic-Gossmann, Sarah Howard, Lars Lind, Craig R. Tomlinson, Jan Vondracek, Jerrold J. Heindel

Publikováno v: Biochemical Pharmacology
Biochemical Pharmacology, 2022, 199, pp.115012. ⟨10.1016/j.bcp.2022.115012⟩
Biochemical Pharmacology, Elsevier, 2022, 199, pp.115012. ⟨10.1016/j.bcp.2022.115012⟩
Biochem Pharmacol
Biochem Pharmacol.

International audience; Obesity is a chronic, relapsing condition characterized by excess body fat. Its prevalence has increased globally since the 1970s, and the number of obese and overweight people is now greater than those underweight. Obesity is

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05c55dd9770a00639bd6f758a0db9dab
https://doi.org/10.1016/j.bcp.2022.115012